ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,991, issued on July 7, was assigned to MEDICOVESTOR INC. (Wilmington, Del.).

"Methods of crosslinking IgG" was invented by Seah Lim (Wilmington, Del.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to dimeric immunotherapeutics that comprise an IgG that is crosslinked with a disulfide bond. The IgG may include two heavy chains including a cysteine mutation that forms the disulfide bond. The dimeric immunotherapeutics are formed by increasing the concentration of the IgG such that spontaneous dimerization via the formation of disulfide bonds between the IgG molecules occurs over time."

The patent was filed on Aug. 30, 2024, und...